Literature DB >> 10511306

Antenatal ultrasonographic diagnosis of rhizomelic chondrodysplasia punctata.

B S Hertzberg1, M A Kliewer, M Decker, C R Miller, J D Bowie.   

Abstract

Rhizomelic chondrodysplasia punctata is an autosomal recessive disorder characterized by stippled epiphyses and rhizomelic shortening of the long bones. Most fetuses with the disorder die in utero or shortly thereafter, and the few that survive suffer severe debility and profound mental retardation. Death ensues in the first decade of life. Relatively few reports discuss antenatal ultrasonographic diagnosis of rhizomelic chondrodysplasia punctata. We describe the prospective antenatal diagnosis of rhizomelic chondrodysplasia punctata in a fetus with no family history of the disorder, based on the sonographic findings of severe rhizomelic limb shortening in combination with premature ossification and stippling of multiple epiphyses. The ultrasonographic features and differential diagnosis of rhizomelic chondrodysplasia punctata are elaborated.

Entities:  

Mesh:

Year:  1999        PMID: 10511306     DOI: 10.7863/jum.1999.18.10.715

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  3 in total

1.  Severe nasomaxillary hypoplasia (Binder phenotype) on prenatal US/MRI: an important marker for the prenatal diagnosis of chondrodysplasia punctata.

Authors:  Anna R Blask; Eva I Rubio; Kimberly A Chapman; Anne K Lawrence; Dorothy I Bulas
Journal:  Pediatr Radiol       Date:  2018-03-23

2.  Rhizomelic chondrodysplasia punctata type 1: report of mutations in 3 children from India.

Authors:  S R Phadke; N Gupta; K M Girisha; M Kabra; M Maeda; E Vidal; A Moser; S Steinberg; R D Puri; I C Verma; N Braverman
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

3.  A new GNPAT variant of foetal rhizomelic chondrodysplasia punctata.

Authors:  Adalgisa Cordisco; Elisabetta Pelo; Mariarosaria Di Tommaso; Roberto Biagiotti
Journal:  Mol Genet Genomic Med       Date:  2021-06-10       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.